Physician profile
Megan Tasker
NPI 1235576265
$8,089.51
in general payments reported to CMS, 2019-2025
11 companies · $96.65 in 2025
The $96.65 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,454 · 2020: $206 · 2021: $2,096 · 2022: $134 · 2024: $102 · 2025: $96.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,232.05 | 2019-2021 | |
| Integra Lifesciences Corporation | $221.36 | 2021-2022 | |
| Smith+Nephew, INC. | $217.39 | 2020-2025 | Grafix Pl |
| Organogenesis INC. | $124.34 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.19 | 2021-2022 | |
| Convatec INC. | $63.96 | 2020-2022 | |
| Solventum Corporation | $49.83 | 2025 | 3m Coban, Activ.A.C., 3m Cavilon |
| Takeda Pharmaceuticals U.S.A., INC. | $44.16 | 2020-2021 | |
| Kerecis Limited | $24.40 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tela Bio, INC. | $16.32 | 2022 | |
| Medela LLC | $10.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Tasker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.